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Instrumentation for the detection and follow-
up of lung disease is frequently lacking in 
physicians' offices and clinics. However , equip-
ment for diagnosis and follow-up of heart dis-
ease such as the electrocardiogram (ECG) is 
common in these environments. Why the dif-
ference? This difference is especially perplexing 
in light of the fact that some authors have said 
"Spirometry should be pe1formed on most adult 
patients to de tect chronic obstructive pulmo-
nary disease (COPD). "6 The following state-
ments explain, in part, why pulmonary function 
testing, especially spirometry, has not come 
into common use: 
l. The prevalence of lung disease was not known 
to be as widespread as heart disease. However, in 
recent years COPD has become a major public health 
problem. According to Enright and Hyatt," approxi-
mately 17 per cent of men over age 40 have COPD 
and about 5 per cent of women have COPD, and 
the rate of the latter is growing rapidly. 
2. The natural history of lung disease has not been 
as well known as that of heart disease. Recently the 
course of chronic airway obstruction has been stud-
ied. Spirometry is the best test for early de tection of 
COPD. Despite the development of other pulmonary 
function tests that were thought to be more "sensi-
tive" at detecting small airways disease, the ratio of 
the forced expired volume in the first second (FEV1) 
to the forced vital capacity (FVC) is still the easiest 
and best test to use . 6 · 34 Repeated measurements of 
FEV1 allow for detection of smokers who are at high 
risk. Patients in this situation can "normalize" their 
annual decline in FEV1 with smoking cessation. 34 
3. Early de tection of COPD was not associated 
with an effective treatment. However, an effective 
therapy for COPD does exist. Smoking cessation is 
the most important treatment and chronic adminis-
tration of bronchodilator drugs for treatment of 
asthma is well es tablished . 
4. For heart disease the ECG requires only that 
the patient lie still whereas pulmonary function test-
ing requires good patient effort and cooperation. 
Standard methods are now available that make the 
spirometry testing simpler and more effective. 
5. Equipment standards were established quickly 
for ECG but were slow to develop for pulmonary 
function testing. Even though Hutchinson23 pub-
lished the first spirometry results in 1846, more than 
50 years before Einthoven5 reported on the ECG in 
1903, ECG methods were readily standardized. In-
strument standards and methods for pulmonary func-
tion testing are still under development. Recently 
the American Thoracic Society (ATS) established 
recommendations for standardizing spirometry 
equipment and testing methods. 16 
6. Reference standards for diagnosis and deter-
mination of the severity of abnormality were quickly 
established for the ECG but are just now being 
established for spirometry. 
7. Measurements and calculation of results from 
pulmonary function testing are quantitative tasks that 
most physicians and their staffs are not equipped to 
perform. Fortunately, today most spirometers are 
computerized so that the measurement and assess-
ment of spirometry is easier. 
8. Physicians have treated heart disease for many 
years, but only recently have environmental factors 
such as smoking been recognized as causing exacer-
bations of COPD. 
9. The specialty of pulmonary disease is relatively 
new compared with the field of cardiology. 
CHOICE OF PULMONARY FUNCTION 
TEST 
An increasing number of pulmonary function 
tests are being developed and promoted to 
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provide early detection of lung disease or to 
indicate the type and severity of such disease 
more accurately. 6 · 34 These tests include meas-
urement of lung volumes and flows using vol-
ume spirometers, flow meters , body plethys-
mography, helium dilution, and nitrogen 
washout. In spite of all the new developments 
and availability of tests, the forced spirogram is 
still the best test of pulmonary function. 6• 34 
Spirometry is easily applied in the office or 
clinic and should be more widely used. 
Recently there has been a flurry of activity 
to standardize the equipment and methods for 
performance of spirometry. These efforts have 
been spearheaded by the ATS and other inter-
national groups . 7• 12• 16• 27• 34• 35 As a result, there 
are now excellent recommendations for spirom-
etry testing that should help spirometry become 
even a more valuable, frequently used test. 16 
SPIROMETRY: VOLUME-TIME VERSUS 
FLOW-VOLUME 
Spirometers were first used to measure the 
volume of air expired from the lung. The vari-
ables measured were usually the vital capacity 
(VC) or the FVC that were useful only in the 
diagnosis of restrictive lung disease. The first 
clinically useful spirometer was developed by 
Hutchinson23 in 1846. It took more than 100 
years before the value of the timed expiratory 
volume curve for diagnosing airway obstruction 
was recognized by Gaensler. 9• 10 As a result of 
Gaensler's7· 10 pioneering work the FVC maneu-
ver was developed, which allows the measure-
ment of the FEV1 and other time-related meas-
ures of dynamic pulmonary function. Since that 
time there have been a wide variety of devices 
developed for spirometry. These include the 
water-seal, rolling-seal, and bellows-volume 
spirometers , along with the Fleisch and wire 
mesh pneumotachograph flowmeter spirome-
ters. In 1979, after nearly 3 decades of forced 
expiratory spirometry use, the ATS published 
recommendations for spirometry perform-
ance .1 2 
Because there is a slowing of the exhaled 
airflow with airway obstructive lung disease, 
motorized charts were added to the Hutchinson 
water seal spirometer to measure airflow. In 
the early 1950s, it became possible to make 
timed measurements of volume from a graph 
known as a "spirogram." The water-seal Stead-
Wells spirometer was developed in the late 
1950s and is still one of the best devices for 
measuring spirometric results. 36 By using mo-
torized chart recordings , investigators were able 
to measure slopes from the volume-time curves 
and estimate flow. In the early 1960s, it was 
found that an assessment of the obstruction was 
more easily appreciated when expiratory flow 
was plotted against exhaled volume (flow-vol-
ume curve). 
Data obtained from the forced expiratory 
maneuver can be used to generate both the 
flow-volume and volume-time curves. These 
curves contain the same information, but are 
presented in a different format for visualization 
purposes. Computer technology has now re-
solved a controversy about which approach is 
more useful. Since computers can quickly and 
easily display and plot either, both types of 
curves are used. Flow-volume curves "expand" 
the rapid exhalation segment of the forced ex-
piratory maneuver. Flow-volume plots are very 
helpful in detecting inadequate patient effort . 
Volume-time curves present data in a more 
conventional format that can easily be generated 
by simple mechanical spirometers. Figure 1 
illustrates an example of flow-volume and vol-
ume-time curves. With the computer systems 
associated with most spirometers today, it is 
convenient and appropriate to have both dis-
plays available . 
SELECTING A SPIROMETER: 
EQUIPMENT PERFORMANCE CRITERIA 
Equipment selection is pivotal to acquiring 
accurate spirometry results. Recommendations 
for spirometer performance and validation have 
been published by the ATS. 16 The ATS instru-
mentation recommendations should be followed 
to provide accurate spirometric data. By using 
accurate and validated spirometers, information 
from different types of spirometers , from differ-
ent laboratories, and from one time period to 
the next can be appropriately compared. 
The accuracy of a spirometer system depends 
on its resolution and linearity for either volume 
or flow depending on the type of transducer 
used. Because errors can occur at any step in 
the process of data acquisition and display, an 
entire spirometer system must be tested and 
validated. In a recent series of spirometer eval-
uations, computer software problems were re-
sponsible for many of the measurement er-
rors. 3o. 31 
Table 1 summarizes ATS recommendations 
for spirometers. Since the spirometric FVC 
maneuver is the most common test of pulmo-
nary function , its performance and the corre-
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Figure l. Volume-time (A) and flow-volume (B) spirometry curves plotted for the same patient forced expiratory 
maneuver. 
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Table l. Summary of American Thoracic Society Minimal Recommendations for Spirometry Systems 
RESISTANCE AND 
RA!\GEIACCURACY FLOW RANGE TI~IE BACK-PRESSURE 
TEST (BTPS) (Us) (s) (cmH,O/Lis) TEST SIGNAL 
FYC 7 L ± 3% of reading, or 0--12 15 24 standard waveforms 
± 0.050 L, whichever is 
greater 
FEY, 7 L ± 3% of reading, or 0--12 t* < 1.5 from 0--12 Us 24 standard waveforms 
± 0.050 L, whichever is 
greater 
FEF,_,.., 7 L ± 5% of reading, or 0--12 15 Same as FEY, 24 standard waveforms 
± 0.200 Us, whichever is 
v 
greater 
± 12 Us ± 5% of reading, or 0--12 15 Same as FEY, Manufacturer provided 
± 0.200 Us, whichever is proof 
greater 
*Time zero (t) is the time point from which all FEY, measurements are taken . It is determined by back-extrapolation . 
sponding measure of equipment performance 
are discussed in detail. 
AMERICAN THORACIC SOCIETY 
RECOMMENDATIONS FOR 
SPIROMETRY 
Forced Vital Capacity 
The FVC is the maximal volume of air ex-
haled with maximally forced effort from a posi-
tion of maximal inspiration . FVC is the VC 
performed with a maximally forced expiratory 
effort and is expressed in L (BTPS), where 
BTPS indicates body temperature (usually 
37°C), ambient pressure, saturated with water 
vapor. 
Recommendation for Forced Vital Capacity 
Equipment. The spirometer should be capable 
of measuring volumes up to at least 7 L (BTPS) 
with an accuracy of at least ± 3 per cent of the 
reading of ± 0. 050 L, whichever is greater, 
with flows between 0 and 12 L per second. The 
spirometer should be capable of accumulating 
volume for at least 15 seconds , although longer 
times are recommended. 
Timed Forced Expiratory Volume 
The timed forced expiratory volume (FEV,) 
is the volume of air exhaled in the specified 
time during the performance of the FVC, for 
example , FEV 1 for the volume of air exhaled 
during the first second of FVC. It is expressed 
in L (BTPS). 
Recommendation for Timed Forced Expi-
ratory Volume Equipment. Measuring the 
FEV, requires a spirometer having a volume of 
at least 7liters. The spirometer should measure 
the FEV 1 within an accuracy of at least ± 3 per 
cent of the reading or ± 0.050 L, whichever is 
greater with flows between 0 and 12 L per 
second. The "start of test" for purposes of timing 
will be determined by the back-extrapolation 
method or an equivalent method. For hand 
measurements, the back-extrapolation method 
traces back from the steepest slope on the 
volume-time curve. The resistance to air flow 
from 0 to 12.0 L per second should be less than 
1.5 cmH20 per L per second. 
FEF25--7s% 
The FEF 25-75% is the mean forced expiratory 
flow during the middle half of the FVC. It was 
form erly called the maximal mid-expiratory flow 
rate and is expressed in L per second (BTPS). 
Recommendation for FEF 25_75% Equipment. 
The FEF2s-7s% should be measured with an 
accuracy of at least ± 5 per cent of reading or 
± 0. 200 L per second, whichever is greater. 
The FEF2s-7s% should be measured on a system 
that meets the recommendations for FVC 
equipment. 
Flow 
The flow (V) is the instantaneous forced ex-
piratory flow . It is expressed in L per second 
(BTPS). 
Recommendation for Flow Measurement. 
Flow may be measured electronically or man-
ually. When flow-volum e loops or other flow 
measurements are made, at flow rates in the 
range of - 12 to + 12 L per second, the flow 
should be within ± 5 per cent of reading or 
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± 0.200 L per second, whichever is greater. 
The FVC equipment recommendations for time 
should be used. 
Forced Expiratory Time 
The forced expiratory time (FET) is the time 
from the back-extrapolated "time zero" until 
the first inspiratory effort following FVC, or the 
end of expiratory effort. 
Spirometry Recorders/Displays 
Paper records or graphic displays of spirom-
etry signals are required for: 
Diagnostic function when curves are to be 
used for quality control or review of the forced 
expiratory maneuver to determine if the ma-
neuver was performed properly. This enables 
unacceptable maneuvers to be eliminated. 
Validation function when curves are to be 
used to validate the spirometer system hard-
ware and software for accuracy and reliability 
through the use of hand measurements (for 
example, measurement of FEV1 using back-
extrapolation by comparing computer and hand 
determined FEV1s). 
Hand measurement function when curves are 
to be hand-measured for spirometric parame-
ters (FVC, FEV1, and so forth) in the absence 
or failure of a computer. 
With recent advances in computer technol-
ogy, there are many different ways to display 
and record spirometric curves. The ATS Stan-
dardization Committee chose to broaden the 
initial scope of the spirometry standardization 
document to encourage use of computer tech-
nology. 
A less stringent paper recorder requirement 
will suffice for diagnostic purposes compared 
with validation and hand measurement needs . 
If no paper recorder or printer is available or if 
the paper recorder does not meet the require-
ments for validation and hand measurement 
applications, then proof of validation of the 
accuracy and stability of the spirometer by an 
independent laboratory is required of the man-
ufacturer. 
Recorder Recommendations for Forced Vital 
Capacity Volume-Time Curves 
When a volume-time curve is plotted or 
displayed, the minimum volume scale for each 
of the following conditions should be main-
tained: 
Diagnostic function: 5 mm per L (BTPS) for 
volume so the graphs will be large enough to 
allow recognition of unacceptable maneuvers 
and disease patterns. 
Validation and hand measurement functions: 
10 mm per L (BTPS) for volume for validation 
and measurement functions. See the next sec-
tion for the time scale of volume-time plots . 
Recommendations for Forced Vital Capacity 
Maneuver Time Scale 
The minimum time scale for each of the 
following conditions should be maintained: 
Diagnostic function: 1 em per second. 
Validation and hand measurement functions: 
2 em per second. Larger time scales are pre-
ferred (at least 3 em per second) when hand 
measurements are made, but are not required . 
Recommendation for Forced Vital Capacity 
Flow-Volume Curves 
When a flow-volume curve is plotted or dis-
played, exhaled flow should be plotted upward 
and exhaled volume plotted toward the right. 
A 2:1 ratio should be maintained between the 
flow and volume scales, for example, 2 L per 
second of flow and 1 L of exhaled volume should 
be the same distance on their respective axes. 
The minimum flow and volume scales should 
be as shown in Table 2. 
EQUIPMENT VALIDATION 
The diversity ofFVC maneuvers encountered 
in clinical practice is best simulated by the use 
of the 24 standard waveforms. 21 These wave-
forms are best used to drive a computer-con-
trolled mechanical syringe for testing integrated 
spirometers because these waveforms test both 
hardware and software. 16 
Earlier studies of spirometer accuracy have 
found several performance problems. Fitz-
Gerald and coworkers8 found that all seven 
"electronic" spirometers they tested were in-
capable of measuring FVC and FEV1 accurately 
or reproducibly when compared with a water-
seal spirometer. Testing of 12 volume-based 
and 7 flow-based spirometers demonstrated sev-
eral problems . 17 Eight (67 per cent) of the 
volume-based devices performed acceptably, 
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Table 2. Minimum Required Scale Factors f or Time, Volume, and Flow Graphics 
D IAGNOSTIC VALI DATION AND ~I EASURDI ENT 
Resolution Resolution 
Required Scale Factor Required Scale Factor 
Volume (L) 0.050 
(mm/L) 
Flow (U s) 0.20 
(mm/U s) 
Time (ms) 20 
(cm/s) 
whereas all seven of the flow-based devices had 
unacceptable pe1formance . 
With the prolife ration of computerized spi-
rometry systems, it is now important to test 
these systems with eithe r a volume or flow 
transducer as an integrated system rather than 
testing only parts of the system as some authors 
have chosen to do. A volume or flow transducer 
may be inherently accurate and precise, but 
may be attached to a compute r with an inade-
quate sampling rate, inadequate flow or volume 
resolution, inadequate calibration, or deficient 
computational algorithms. 16 There is a continu-
ous flood of reports on the evaluation of spirom-
eter pe1formance. 20• 22• 37- 39 Some are studies 
"funded" by spirometer manufacturers and oth-
ers use "ad hoc" criteria and thus many present 
questionable conclusions. 
We recently conducted studies to determine 
if 57 contemporary spiro meters could meet ATS 
performance criteria when measuring a set of 
24 standard patient spirometry waveforms . 16• 21 
A computer-controlled, stepper motor-driven 
air pump was developed . 29 The pump was then 
used to evaluate 57 contemporary spirome-
ters. 3o. 3 1 
Results of the testing are summarized in 
Table 3. Only 30 (52.6 per cent) of the spirom-
eters pe1formed acceptably when measuring the 







of the 58 spirometers were computerized . Soft-
ware errors were found in 27 per cent of the 
computerized systems evaluated . 
Thus, as a consequence of this testing, the 
purchaser and user of spirometers must take 
great care to be sure that they purchase and 
maintain their spirometers adequately in order 
to reduce the likelihood of erroneous test results 
occurring. 
EQUIPMENT QUALITY CONTROL 
Routine preventive maintenance , cleaning, 
calibration checks, ve rification , and quality con-
trol on equipment are important to ensure 
accurate spirometry results. 11• 14• 16 The spirom-
eter's ability to measure volume accurately 
should be checked at least daily with a cali-
brated syringe with a volume of at least 3 L. 
Although there is minimal day-to-day variation 
in volume calibration, daily calibration checking 
is highly recommended so that the onset of a 
problem can be determined within 1 day, 
the reby eliminating needless reporting of false 
values for several weeks or months . Spirometer 
systems should be evaluated for leaks on a daily 
basis. At least quarterly, volume spirometers 
should have their calibration checked over their 
Table 3. Performance by Spirometer Type 
Bellows 
Wate r seal 
TYPE 
Dry roll ing seal (horizontal) 
Ceramic pne umotachometer 
Hans Rudolph (screen) pneumotach 
Fleisch pneumotachometer 
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entire volume range (in 1-L increments) using 




Interactions between technician and patient 
or subject is crucial to the performance of 
adequate spirometry since it is such an effort-
dependent maneuver. Technicians must be se-
lected and trained , and must maintain a high 
level of proficiency to assure optimum results. 
The ATS has made recommendations for labo-
ratory personnel performing a variety of pul-
monary function testing tasks 15; they are de-
scribed in detail in the article by Mahler and 
Loke elsewhere in this issue . 
Computer Use 
The use of computers to perform spirometry 
has accele rated in the past 5 years. Validated 
computerized spirometry systems will simplify 
and enhance the measurement and interpreta-
tion of spirometry. Because of the increased 
use of computers in pulmonary laboratories and 
the problems associated with them , the ATS 
has published "Computer Guidelines for Pul-
monary Laboratories. "13 
· Instruction and Maneuver 
Subjects should be instructed in the FVC 
maneuver, and the appropriate technique 
should be demonstrated . A minimum of three 
acceptable FVC maneuvers should be per-
formed. If a subject has large variability be-
tween expiratory maneuvers, reproducibility 
criteria may require that up to eight acceptable 
maneuvers be performed. 
End of Test 
Subjects should be verbally exhorted to con-
tinue squeezing out the air at the end of the 
FVC maneuver. "End of Test" will occur when 
there is: 
1. An obvious plateau in the volume-time curve 
resulting in no change in volume for at least 2 seconds 
(a volume decrease is , for the purposes of end-of-test 
selection, equivalent to no change in volume) with 
an exhalation time of at least 6 seconds (longer times 
are frequently needed for subjects with airway ob-
struction). For the purposes of this criterion, no 
change in volume is the minimal detectable volume 
of the spirometer. Minimum detectable volume must 
be at least 0. 040 L; or 
2. A forced exhalation of reasonable duration . (For 
example , exhalation times of greater than 15 seconds 
in subjects with severe airway obstruction will rarely 
change clinical decisions and longer exhalations are 
seldom justified); or 
3. When , for legitimate clinical reasons, the sub-
ject cannot or should not continue further exhalation. 
Although the end-of-test criteria defined pre-
viously are reasonable and adequate in most 
situations, spirometers should not prevent the 
continued accumulation of volume after the end 
of test criteria are met. 
Minimum Forced Vital Capacity Exhale Time 
A minimum exhalation time of 6 seconds, 
unless there is an obvious plateau, is required 
to obtain maximal FVC results. Longer times 
are often required to achieve "end of test," 
particularly in individuals with airway obstruc-
tion . 
Satisfactory Start of Test 
To achieve accurate "time zero" and ensure 
that the FEV1 comes from a maximal effort 
curve, the extrapolated volume should be less 
than 5 per cent of the FVC or 0.100 L, which-
ever is greater. 
Maximum Number of Maneuvers 
Although the re may be some circumstances 
in which more than eight consecutive FVC 
maneuvers are needed, eight maneuvers are 
considered a practical upper limit for most 
subjects . 
Environmental Conditions 
Spirometric testing with ambient tempera-
tures of less than 17°C or above 40°C is not 
recommended. Ambient temperature should al-
ways be recorded and reported to an accuracy 
of ± 1°C. Spirometer users should be aware of 
" . 
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the problems associated with testing performed 
at lower temperatures. 
Nose Clips 
Use of nose clips is encouraged but not ' 
required. 
TEST SELECTION AND REPORTING 
OF RESULTS 
The largest FVC and the largest FEV1 (BTPS) 
should be recorded, after one examines the data 
from all of the acceptable curves, even if the 
two values do not come from the same curve. 
Othl'!r measures such as the FEF 25-75% and/or 
the V should be obtained from the single "best-
test" curve. The "best-test" curve is defined as 
the test that meets the acceptability criteria and 
gives the largest sum of FVC plus FEY 1. 16 
FVC Maneuver Acceptability 
Acceptability will be determined by ascer-
taining that the previously outlined recommen-
dations above are followed. In addition the 
technician should make certain that the subject 
understood the instructions and performed the 
maneuver with a maximum inspiration, with a 
good start, with a smooth continuous exhalation, 
with maximal effort, and without the following: 
1. An unsatisfactory start of expiration, character-
ized by excessive hesitation or false start, or extrap-
olated volume of greater than 5 per cent of FVC or 
0.100 L, whichever is greater. 
2. Coughing during the first second of the maneu-
ver, thereby affecting the measured FEY, value, or 
any other cough, which, in the technician's judg-
ment, interferes with measurement of accurate re-
sults. 
3. Valsalva maneuver (glottis closure). 
4. Early termination of expiration . (In a normal 
subject this would be before completion of the 
breath-usually less than a 6-second maneuver. In 
an obstructed subject a longer time is required. ) 
5. A leak. 
6. An obstructed mouth piece, e.g. obstruction 
due to the tongue being placed in front of the 
mouthpiece, false teeth falling in front of the mouth-
piece, and so forth. 
Determining Reproducibility of Results 
As a goal during test result performance, the 
largest FVC and second largest FVC from ac-
ceptable curves should not vary by more than 
5 per cent of the reading (expressed as a per-
centage of the largest observed FVC regardless 
of the curve on which it occurred) or 0.100 L, 
whichever is greater. In addition to the FVC 
criteria, the largest FEV1 and the second largest 
FEY, (expressed as a percentage of the largest 
observed FEV1 regardless of the curve on which 
it occurred) should not vary by more than 5 per 
cent of the reading or 0.100 L, whichever is 
greater. 
The reproducibility criteria are used as a 
guide to whether more than three FVC maneu-
vers are needed; these criteria are not to be 
used for excluding results from reports or for 
excluding subjects from a study. Unacceptable 
maneuvers should be discarded before applying 
the reproducibility criteria. 
The only criterion for unacceptable subject 
performance, requiring elimination from fur-
ther consideration, is the generation of fewer 
than two acceptable curves. No spirogram 
should be rejected solely on the basis of its poor 
reproducibility, provided three acceptable ma-
neuvers were obtained. Reproducibility of re-
sults should be considered at the time of inter-
pretation . Use of data from maneuvers with 
poor reproducibility is left to the discretion of 
the interpreter. 
SELECTING REFERENCE VALVES 
Most laboratory tests of organ function are 
measured and "normalized" to a function of 
body size; for example, hemoglobin is usually 
reported in relation to mL of blood rather than 
total blood volume. 1 Spirometry values are usu-
ally reported in absolute units of L. Tradition-
ally the major determinants of"normality" have 
been made by comparing the results obtained 
with those found in a healthy person of the 
same age, sex, and size .1• 3• 19• 22• 24-26 Expected 
or reference values are derived from prediction 
equations describing the relationship of lung 
function to sex, age, and height at the mini-
mum. This area of spirometry standardization 
is at an early stage in its development. The ATS 
held a workshop with international participants 
to address "Lung Function Testing: Selecting 
Reference Values and Interpretative Strategies" 
in September 1988. The final conclusion and 
recommendations from this workshop are not 
yet available. However, some of the concepts 
and concerns discussed at the conference will 
be of value to those performing spirometry. 
The prediction equations selected must be 
. . 
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appropriate to the patients or subjects under 
study. Some prediction equations have been 
based on studies of unique religious and ethnic 
groups, which may not be representative of 
white Europeans or Americans as a whole. 24 
For example, from studies of black populations 
the various measurements of lung functions 
appear to be 13.2 per cent larger for a given 
height in whites when compared with blacks. 33 
Thus, the use of this scaling factor offers a 
reasonable approximation to adapt white pre-
dicted values to blacks . 
Recent evidence has shown that socioeco-
nomic status has a major effect on pulmonary 
function . 24 For example, following a change to 
western diet and attitudes , the body and lung 
sizes of Chinese and Japanese individuals have 
increased to values similar to those of whites. 
All currently available prediction equations 
are based on cross-sectional data. Conse-
quently, they should not be used to predict 
longitudinal changes. Indeed, the prediction 
equations of today will inevitably become ob-
solete, and frequent (perhaps every 10 years) 
revisions will be necessary. 
The Inte rmountain Thoracic Society has re-
cently published its manual of uniform labora-
tory procedures. 28 This manual contains tables 
for reference values as well as interpretive 
strategies in both table and computer pro-
grams. 4· 28 The California Thoracic Society has 
published a similar book that emphasized the 
controversy associated with selecting reference 
values and interpretation methodology. 2 Addi-
tional texts dealing with these issues are avail-
able as well. 3• 26 
INTERPRETATION OF RESULTS 
In terms of the use of spirometry test results , 
the definition of "normal" is usually intended 
to provide a range of reference values to which 
one can compare measured values and associate 
them with risk factors of disease categoriza-
tion . 25 Three general methods are used for 
establishing the lower limits of "normal' ': 
1. The predicted value ± a "magic value" as a 
percentage of predicted (for example, the "magic 
value" of less than 20 per cent of predicted, which 
is used for many lung function tests , or an FEV/ 
FVC ratio of less than 70 per cent). 
2. The 95th percentile method: Yl easured values 
are expressed as a percentage of predicted . The lower 
limit of normal is defined as the value above which 
95 per cent of a normal population lies. 
3. The 95 per cent confidence interval (CI) 
method: The lower limit of normal is defined as the 
predicted value minus the 95 per cent CL The 95 
per cent CI is close to 1. 96 x the standard error of 
the estimate (SEE) for a two-tailed test and 1.65 x 
SEE for a one-tailed test. 
Method 1 has little scientific or statistical 
validity and has very little to recommend it 
except for tradition and convenience. Method 
2 has the best scientific and statistical founda-
tion , 25 but for the moment suffers from the lack 
of sufficient data from published reference stud-
ies to be easily applied. 28 Thus, for the moment 
Method 3 using the CI method seems most 
appropriate. Details involving the application 
of the method are found in the Intermountain 
Thoracic Society's "Orange ManuaL "28 
The classification of spirometry into normal 
and abnormal groupings and into disease cate-
gories such as mild, moderate, and severe air-
way obstruction is easily accomplished once 
criteria have been established . 28 The meaning 
of such classifications requires clinical informa-
tion. For example, the meaning of an FVC 
measurement that is just below the lower limit 
of normal is different in a young, healthy, 
nonsmoking individual than it is in a person 
who presents for evaluation of dyspnea or who 
has an abnormal chest radiograph. In the first 
case, the probability of a false-positive test is 
large since the prior probability of disease is 
very low. In the second case, the probability of 
a true-positive test is high because the symp-
toms and/or the abnormal radiograph increases 
the prior probability of disease . 
CONCLUSION 
Spirometry is currently being used to make 
decisions about individual patients such as: 
Does this subject have enough evidence of 
impaired lung function to preclude working at 
a specific job? Should corticosteroid treatment 
be continued? Does the person qualifY for full 
disability compensation on the basis of impaired 
lung function ? Should the subject's insurance 
status be changed? Answers to each of these 
questions can be based on results from the 
forced expiratory spirometric maneuvers and 
can have a dramatic effect on a person's lifestyle, 
standard of living, and future treatment. There-
fore, it is incumbent on those who perform 
spirometric testing to be certain that the equip-
ment meets ATS recommendations and that the 
techniques that elicit best patient effort are 
applied. Methods and suggestions have been 
154 Reed M. Gardner et al. 
presented in this article that should assist in 
these important tasks. 
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